C000252142 Holdings — JNL/T. Rowe Price Capital Appreciation Equity Fund
All 92 reported holdings of JNL/T. Rowe Price Capital Appreciation Equity Fund (C000252142) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Amazon.com, Inc. | 5.86% | $61.52M |
| NVIDIA Corporation | 5.34% | $56.07M |
| Microsoft Corporation | 5.18% | $54.37M |
| Apple Inc. | 4.74% | $49.81M |
| Alphabet Inc. | 4.41% | $46.31M |
| Meta Platforms, Inc. | 4.22% | $44.38M |
| Broadcom Inc. | 3.18% | $33.39M |
| Advanced Micro Devices, Inc. | 3.12% | $32.76M |
| CenterPoint Energy, Inc. | 3.05% | $32.02M |
| Keurig Dr Pepper Inc. | 2.62% | $27.55M |
| Taiwan Semiconductor Manufacturing Company Limited | 2.60% | $27.31M |
| NiSource Inc. | 2.45% | $25.69M |
| MasterCard Incorporated | 2.09% | $21.93M |
| Micron Technology, Inc. | 2.08% | $21.84M |
| Cencora, Inc. | 2.04% | $21.48M |
| JPMorgan Chase & Co. | 1.90% | $20.00M |
| Waters Corporation | 1.81% | $19.06M |
| PPL Corporation | 1.68% | $17.62M |
| Ameren Corporation | 1.67% | $17.55M |
| Danaher Corporation | 1.63% | $17.11M |
| Visa Inc. | 1.59% | $16.75M |
| Cytokinetics, Incorporated | 1.35% | $14.17M |
| Revvity, Inc. | 1.31% | $13.75M |
| Starbucks Corporation | 1.29% | $13.55M |
| PTC Inc. | 1.25% | $13.10M |
| Ascendis Pharma A/S | 1.25% | $13.10M |
| Canadian Natural Resources Limited | 1.23% | $12.88M |
| Ingersoll Rand Inc. | 1.22% | $12.85M |
| Apogee Therapeutics, Inc. | 1.18% | $12.40M |
| Arthur J. Gallagher & Co. | 1.16% | $12.20M |
| Becton, Dickinson and Company | 1.16% | $12.14M |
| Yum! Brands, Inc. | 1.13% | $11.88M |
| Jackson National Asset Management, LLC | 1.10% | $11.54M |
| DoorDash, Inc. | 1.09% | $11.45M |
| UnitedHealth Group Incorporated | 1.09% | $11.40M |
| Alphabet Inc. | 1.01% | $10.60M |
| KLA Corporation | 1.00% | $10.50M |
| Alnylam Pharmaceuticals, Inc. | 0.99% | $10.38M |
| US Foods Holding Corp. | 0.77% | $8.11M |
| Aurora Innovations Inc. | 0.68% | $7.15M |
| Northrop Grumman Corporation | 0.66% | $6.98M |
| Veralto Corporation | 0.66% | $6.92M |
| Lockheed Martin Corporation | 0.65% | $6.85M |
| Eli Lilly and Company | 0.61% | $6.39M |
| Cadence Design Systems, Inc. | 0.59% | $6.15M |
| ASML Holding N.V. | 0.57% | $5.97M |
| Arista Networks, Inc. | 0.55% | $5.82M |
| Willis Towers Watson Public Limited Company | 0.52% | $5.44M |
| Chevron Corporation | 0.52% | $5.43M |
| Vaxcyte, Inc. | 0.51% | $5.40M |
| MSCI Inc. | 0.48% | $5.07M |
| Synopsys, Inc. | 0.47% | $4.95M |
| WEC Energy Group Inc. | 0.45% | $4.73M |
| Philip Morris International Inc. | 0.45% | $4.68M |
| West Pharmaceutical Services, Inc. | 0.44% | $4.62M |
| Bentley Systems, Incorporated | 0.43% | $4.52M |
| KKR & Co. Inc. | 0.39% | $4.13M |
| HCA Healthcare, Inc. | 0.38% | $3.98M |
| Waste Connections, Inc. | 0.38% | $3.96M |
| General Electric Company | 0.37% | $3.89M |
| SPX Technologies, Inc. | 0.37% | $3.86M |
| TE Connectivity Public Limited Company | 0.35% | $3.65M |
| Gilead Sciences, Inc. | 0.33% | $3.46M |
| TransDigm Group Incorporated | 0.32% | $3.35M |
| Ares Management Corporation | 0.31% | $3.22M |
| JNL Government Money Market Fund | 0.29% | $3.05M |
| Biogen Inc. | 0.28% | $2.96M |
| Sphere Entertainment Co. | 0.28% | $2.93M |
| Arxis, Inc. | 0.27% | $2.86M |
| Netflix, Inc. | 0.27% | $2.78M |
| Ciena Corporation | 0.26% | $2.74M |
| ConocoPhillips | 0.25% | $2.62M |
| Abbott Laboratories | 0.25% | $2.59M |
| S&P Global Inc. | 0.24% | $2.55M |
| CG Oncology, Inc. | 0.23% | $2.42M |
| IDEX Corporation | 0.23% | $2.40M |
| Service Corporation International | 0.22% | $2.36M |
| Republic Services, Inc. | 0.19% | $2.01M |
| Marriott International, Inc. | 0.19% | $2.01M |
| Kymera Therapeutics, Inc. | 0.19% | $1.99M |
| ITT Inc. | 0.17% | $1.82M |
| Denali Therapeutics Inc. | 0.16% | $1.67M |
| Hilton Worldwide Holdings Inc. | 0.16% | $1.63M |
| Erasca, Inc. | 0.14% | $1.47M |
| General Motors Company | 0.13% | $1.41M |
| Entergy Corporation | 0.12% | $1.24M |
| Dyne Therapeutics Inc. | 0.11% | $1.13M |
| Ryan Specialty Group Holdings, Inc. | 0.08% | $869.65K |
| MoonLake Immunotherapeutics AG | 0.04% | $464.53K |
| Cerebras Systems Inc. | 0.04% | $375.70K |
| T. Rowe Price Government Reserve Fund | 0.00% | $1.98K |
| Gilead Sciences, Inc. | 0.00% | $0 |
C000252142 overview: performance, fees, allocation and SEC filings